Peptech Limited (ASX: PTD) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Peptech Limited (ASX: PTD)

An SI Board Since April 1998

Posts	SubjectMarks	Bans
5	1	0

Emcee: Angelo Ferraro	Type: Unmoderated

Introduction Compact

This company, listed on the Australian Stock Exchange, has been languishing in the low 20c range for a number of months. A far cry from the $3.00 it peaked at earlier this decade.
Their web page is at peptech.com.au

Objective and Strategies of the Company:

The Company focuses on the research and development of peptides, which are ubiquitous in nature and mediate a wide variety of physiological functions. The Company is continually seeking ways to enhance its level of expertise as a developer of peptide-based drugs through identification of novel biological targets, improved screening systems and drug delivery systems.

Peptech is pursuing two main objectives:

Human Pharmaceuticals
To identify and develop clinically important, peptide-based drugs for the treatment of diseases in the areas of cancer, inflammation and infection.
These diseases are linked through the important role of the immune system in their cause and control. Peptech focuses on the development of drugs which can influence the function and regulation of the immune system to benefit the patient. Peptech believes that the key to the identification of safer and more efficacious drugs for immunological regulation rests in selectivity of action. By modifying peptide structures and delivery characteristics, Peptech is development drug candidates which address important clinical needs.

Animal Health
To develop and register peptide-based veterinary products for use in the management of animal health and fertility.

Peptech Animal Health aims to achieve this objective by further progressing its existing products and by building on its unique and proprietary delivery technologies for peptides. Peptech has developed extensive intellectual property relating to the production and delivery of GnRH, a peptide with a central role in the control of animal fertility.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
5	<b>Peptech gets a boost from Pfizer funding agreement</b> By Robe	Angelo Ferraro	-	12/28/1998
4	am I the only one interested in this stock? When I first created this subject	Angelo Ferraro	-	12/20/1998
3	the following may explain the recent rise in the stock: Peptech Limited was to	Angelo Ferraro	-	12/9/1998
2	<b>Peptech up on FDA approval of Ovuplant</b> SYDNEY, June 22 (Re	Angelo Ferraro	-	6/22/1998
1	Interesting developments over the past few weeks. Price has shot up, but very v	Angelo Ferraro	-	6/20/1998

Go to reply# or date (mm/dd/yy):